Drugs that contain Beclomethasone Dipropionate
1. Qnasl patents expiration
QNASL's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US5683677 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Nov, 2014
(9 years ago) | |
| US5776432 | TEVA BRANDED PHARM | Beclomethasone solution aerosol formulations |
Jul, 2015
(8 years ago) | |
| US7780038 | TEVA BRANDED PHARM | Dispensing apparatus with dosage counter |
Jan, 2027
(2 years from now) | |
| US10188811 | TEVA BRANDED PHARM | Nasal spray device |
Oct, 2031
(7 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Strength(NS) | Dec 17, 2017 |
| New Product(NP) | Mar 23, 2015 |
Market Authorisation Date: 17 December, 2014
Treatment: NA
Dosage: AEROSOL, METERED;NASAL
More Information on Dosage
QNASL family patents
2. Qvar 40 patents expiration
QVAR 40 Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US5683677 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Nov, 2014
(9 years ago) | |
| US5776432 | TEVA BRANDED PHARM | Beclomethasone solution aerosol formulations |
Jul, 2015
(8 years ago) | |
| US6446627 | TEVA BRANDED PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US11395889 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
Market Authorisation Date: 15 September, 2000
Treatment: Treatment of asthma
Dosage: AEROSOL, METERED;INHALATION
How can I launch a generic of QVAR 40 before it's drug patent expiration?
More Information on Dosage
QVAR 40 family patents
3. Qvar 80 patents expiration
QVAR 80 Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US5683677 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Nov, 2014
(9 years ago) | |
| US5776432 | TEVA BRANDED PHARM | Beclomethasone solution aerosol formulations |
Jul, 2015
(8 years ago) | |
| US6446627 | TEVA BRANDED PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US11395889 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
Market Authorisation Date: 15 September, 2000
Treatment: Treatment of asthma
Dosage: AEROSOL, METERED;INHALATION
How can I launch a generic of QVAR 80 before it's drug patent expiration?
More Information on Dosage
QVAR 80 family patents
4. Qvar Redihaler patents expiration
QVAR REDIHALER Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6446627 | NORTON WATERFORD | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US7637260 | NORTON WATERFORD | Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber |
Aug, 2020
(3 years ago) | |
| US8132712 | NORTON WATERFORD | Metered-dose inhaler |
Sep, 2028
(4 years from now) | |
| US11395889 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10086156 | NORTON WATERFORD | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US10022510 | NORTON WATERFORD | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10022509 | NORTON WATERFORD | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US10695512 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US8931476 | NORTON WATERFORD | Inhaler |
Jul, 2031
(7 years from now) | |
| US10561808 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US11793953 | NORTON WATERFORD | Inhalers and related methods |
Jan, 2038
(13 years from now) | |
| US11395888 | NORTON WATERFORD | Inhalers and related methods |
Jan, 2038
(13 years from now) | |
| US10792447 | NORTON WATERFORD | Breath actuated inhaler |
Jan, 2039
(14 years from now) | |
| US11559637 | NORTON WATERFORD | Inhalers and related methods |
Jul, 2039
(15 years from now) | |
| US11583643 | NORTON WATERFORD | Inhalers and related methods |
Aug, 2041
(17 years from now) | |
Market Authorisation Date: 03 August, 2017
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
QVAR REDIHALER family patents